Nontherapeutic Risk Factors of Different Grouped Stage IIIC Breast Cancer Patients’ Mortality: A Study of the US Surveillance, Epidemiology, and End Results Database

Figure 2

Kaplan–Meier analysis of DSS. (a). Kaplan–Meier estimates of DSS for patients with stage IIIC breast cancer. (b). Kaplan–Meier analysis comparing DSS in patients with different ER statuses. (c). Kaplan–Meier analysis comparing DSS in patients with different PR statuses. (d). Kaplan–Meier analysis comparing DSS in patients with different molecular typing. (e). Kaplan–Meier analysis comparing DSS in patients with different T stages. (f). Kaplan–Meier analysis comparing DSS in patients with different N3 stages. (g). Kaplan–Meier analysis comparing DSS in patients with different LNP. (h). Kaplan–Meier analysis comparing DSS in patients with different LNR. DSS: disease-specific survival. ER: estrogen receptor. LNP: positive lymph nodes. LNR: lymph node ratio. PR: progesterone receptor.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)